Profile | GDS4284 / 219503_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 50.1905 | 25 |
GSM687648 | Patient 402 control | 177.547 | 47 |
GSM687653 | Patient 403 control | 18.1157 | 11 |
GSM687658 | Patient 404 control | 94.3974 | 33 |
GSM687663 | Patient 411 control | 255.323 | 52 |
GSM687668 | Patient 422 control | 222.689 | 51 |
GSM687673 | Patient 424 control | 238.828 | 50 |
GSM687678 | Patient 425 control | 98.5277 | 33 |
GSM687683 | Patient 427 control | 101.442 | 33 |
GSM687688 | Patient 428 control | 26.3618 | 16 |
GSM687695 | Patient 441 control | 425.341 | 58 |
GSM687699 | Patient 443 control | 221.421 | 47 |
GSM687704 | Patient 444 control | 248.197 | 53 |
GSM687707 | Patient 448 control | 143.77 | 37 |
GSM687712 | Patient 449 control | 99.5914 | 34 |
GSM687719 | Patient 450 control | 116.932 | 33 |
GSM687724 | Patient 451 control | 247.395 | 51 |
GSM687728 | Patient 452 control | 176.012 | 44 |
GSM687646 | Patient 401 treated 24h | 42.1113 | 21 |
GSM687649 | Patient 402 treated 24h | 77.2871 | 32 |
GSM687665 | Patient 411 treated 24h | 163.959 | 42 |
GSM687651 | Patient 402 treated 4 weeks | 236.057 | 50 |
GSM687667 | Patient 411 treated 4 weeks | 111.771 | 36 |
GSM687670 | Patient 422 treated 24h | 167.634 | 43 |
GSM687671 | Patient 422 treated 4 weeks | 121.075 | 39 |
GSM687654 | Patient 403 treated 24h | 32.3059 | 19 |
GSM687675 | Patient 424 treated 24h | 99.4939 | 32 |
GSM687685 | Patient 427 treated 24h | 114.693 | 37 |
GSM687656 | Patient 403 treated 4 weeks | 15.4997 | 11 |
GSM687677 | Patient 424 treated 4 weeks | 148.174 | 43 |
GSM687687 | Patient 427 treated 4 weeks | 55.0108 | 26 |
GSM687692 | Patient 428 treated 4h | 93.8236 | 33 |
GSM687716 | Patient 449 treated 4h | 109.875 | 36 |
GSM687722 | Patient 450 treated 4h | 108.777 | 33 |
GSM687680 | Patient 425 treated 24h | 214.93 | 49 |
GSM687690 | Patient 428 treated 24h | 77.5777 | 30 |
GSM687700 | Patient 443 treated 24h | 154.596 | 35 |
GSM687705 | Patient 444 treated 24h | 55.7287 | 26 |
GSM687714 | Patient 449 treated 24h | 49.2768 | 24 |
GSM687721 | Patient 450 treated 24h | 178.648 | 42 |
GSM687682 | Patient 425 treated 4 weeks | 115.242 | 38 |
GSM687694 | Patient 428 treated 4 weeks | 75.946 | 31 |
GSM687702 | Patient 443 treated 4 weeks | 169.363 | 43 |
GSM687718 | Patient 449 treated 4 weeks | 206.635 | 49 |
GSM687723 | Patient 450 treated 4 weeks | 204.801 | 48 |
GSM687661 | Patient 404 treated 4h | 126.19 | 38 |
GSM687710 | Patient 448 treated 4h | 223.387 | 51 |
GSM687726 | Patient 451 treated 4h | 143.473 | 38 |
GSM687730 | Patient 452 treated 4h | 29.9126 | 5 |
GSM687660 | Patient 404 treated 24h | 307.92 | 54 |
GSM687697 | Patient 441 treated 24h | 424.944 | 59 |
GSM687709 | Patient 448 treated 24h | 161.634 | 42 |
GSM687725 | Patient 451 treated 24h | 362.319 | 57 |
GSM687729 | Patient 452 treated 24h | 462.053 | 62 |
GSM687727 | Patient 451 treated 4 weeks | 329.469 | 56 |
GSM687731 | Patient 452 treated 4 weeks | 194.583 | 45 |